Outsourced Pharma Webinars

  1. How Sponsors Should Evaluate Manufacturing Resilience 9/3/2026

    Learn how continuity planning, technology transfer capabilities, global network flexibility, and digital visibility contribute to resilient supply chains and help protect programs from disruption.

  2. Intensification Of Upstream Operations With Dynamic Perfusion 9/3/2026

    Dynamic perfusion simplifies continuous cell culture by eliminating cell bleed. Compare upstream strategies across productivity to understand their potential for more efficient mAb production.

  3. A CCS Is A Purpose-Built Machine, Not A Black Box: Understand The Workings 9/2/2026

    Learn how to transform your contamination control strategy into a dynamic operational framework that identifies risks and strengthens facility control.

  4. Sterilizing-Grade Filtration Of mRNA Encapsulated Lipid-Nanoparticles 9/2/2026

    Compare sterilizing-grade membrane performance at high and low pressures, including throughput, bacterial retention, and the effects of filtration on particle diameter and encapsulation efficiency.

  5. Role Of Membrane Chemistry And Filter Format In TFF 9/2/2026

    Compare hollow fiber and flat sheet TFF formats across three membrane chemistries, and see how filter selection can influence ambient-temperature UF/DF optimization, processing time, and quality.

  6. Enhancing mRNA-LNP Downstream Processing Via Single-Pass TFF 9/2/2026

    Single-pass tangential flow filtration effectively concentrates mRNA-LNPs and removes ethanol while maintaining quality. See how this approach produced LNPs with 4.2-fold higher in vitro potency.

  7. How Cell Therapy's Fundamentally Different Model Impacts Patients 9/1/2026

    Examine the evolution of autologous CAR T therapies, their patient-specific manufacturing workflow, key similarities and differences with biologics production, and real-world approaches.

  8. Viral Safety Considerations In Process Development 9/1/2026

    Explore how upstream media filtration and downstream anion exchange chromatography can work together to manage viral risk, strengthen AAV process development, and support reliable GMP production.

  9. Genomic Medicine At An Inflection Point 9/1/2026

    In vivo therapies and streamlined ex vivo manufacturing are redefining genomic medicine. Understand the tradeoffs, priorities, and technical challenges influencing how future treatments are designed.

  10. A Practical Roadmap For Column Sizing, System Selection, And GxP Readiness 9/1/2026

    Chromatography scale-up depends on aligning different factors. Learn which factors can help maintain process consistency, manage risk, and support the transition from development to manufacturing.